Sidra Medical appoints William F. Owen Jr. as CEO

Thursday, July 26, 2012 04:18 PM

American healthcare leader Dr. William F. Owen, Jr., M.D., FACP, has been appointed CEO of Sidra Medical and Research Center, a Qatar-based medical, research and education institution that focuses on the health and well-being of women and children, effective August 5, 2012.

Owen's most recent executive role was president of the University of Medicine and Dentistry of New Jersey (UMDNJ), America's largest, publicly funded academic health system. As a seasoned academic health system leader, he has substantive experience building and managing international health and educational services in several of America's elite universities.

Owen will be responsible for the strategic direction of all clinical and operational services of the Sidra Medical and Research Center and lead Sidra to deliver the highest standard of patient care. Reporting directly to the Sidra’s board of governors, his first responsibility will be planning, commissioning and launching the state-of-the-art Sidra facility in line with its vision and targets. Owen will also be responsible for further recruitment and leadership of the executive team at Sidra.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs